ADC / XDC

Delve into the world of ADC / XDC in China’s pharmaceutical industry. Fineline Info & Tech provides reliable data, news, and insights on ADC / XDC to help you navigate complexities with precision and clarity. Stay informed and enhance your decision-making at flcube.com.

Danatlas Pharmaceuticals Wins NMPA IND Approval for DAT‑6618 – China's First PPARγ Inhibitor to Enter Clinical Development
CompanyDrug

Danatlas Pharmaceuticals Wins NMPA IND Approval for DAT‑6618 – China’s First PPARγ Inhibitor to Enter Clinical Development

Danatlas Pharmaceuticals announced that the Investigational New Drug (IND) application for DAT‑6618, an independently developed PPARγ inhibitor, has been approved by China's National Medical Products Administration (NMPA). DAT‑6618 is the…

Ribo Life Science Opens Automated Intelligent Drug Screening Center – A Key Leap in AI‑Powered siRNA Drug Discovery

Ribo Life Science Opens Automated Intelligent Drug Screening Center – A Key Leap in AI‑Powered siRNA Drug Discovery

CSPC to Unveil Data From 8 Oncology Trials at ESMO Congress 2026 – Anbenitamab Phase III Results Headline Two Late‑Breaking Abstracts

CSPC to Unveil Data From 8 Oncology Trials at ESMO Congress 2026 – Anbenitamab Phase III Results Headline Two Late‑Breaking Abstracts

Empowering Chinese Pharma’s Global Expansion

Leverage premier media reach to connect your pipeline with global partners. Contact us to drive your international growth today.
Explore Now
CompanyDeals

BioNTech Expands Partnership with Duality Biologics for Global Rights to ADC DB-1305

CompanyDeals

InxMed Partners with GeneQuantum Healthcare to Develop Innovative ADCs

CompanyDrug

Jiangsu Hengrui Pharmaceuticals and Hansoh Pharmaceutical Group Get NMPA Approval for Solid Tumor Treatment

CompanyDrug

Mabwell Bioscience’s 7MW3711 ADC for B7-H3 Gets Clinical Trial Approval in China

CompanyDrug

Jiangsu Hengrui Pharmaceuticals Gets NMPA Approval for SHR-A1811 and Pyrotinib Combo Study

CompanyDrug

Mabwell Bioscience Receives NMPA Approval to Launch 9MW2921 Clinical Study

CompanyDeals

GeneQuantum Healthcare and Aimed Bio Expand Partnership to Develop Five Novel ADC Drugs

CompanyDrug

AstraZeneca and Daiichi Sankyo’s Enhertu Gains New Indication Approval in China for HER2-Low Breast Cancer

Show More